SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults

NCT00461500 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Salmeterol xinafoate/fluticasone propionate combination
DRUG: Fluticasone propionate

Sponsor

GlaxoSmithKline